Related references
Note: Only part of the references are listed.Retinal transcriptome profiling identifies novel candidate genes associated with visual impairment in a mouse model of multiple sclerosis
Sungmoo Hong et al.
ANIMAL CELLS AND SYSTEMS (2023)
Synapto-protective effect of lithium on HIV-1 Tat-induced synapse loss in rat hippocampal cultures
Namgue Hong et al.
ANIMAL CELLS AND SYSTEMS (2022)
Structural Plasticity of the Hippocampus in Neurodegenerative Diseases
Poornima D. E. Weerasinghe-Mudiyanselage et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents-in celebration of 80th birthday of Professor Peter Riederer
Masaru Tanaka et al.
JOURNAL OF NEURAL TRANSMISSION (2022)
Changes in the Neuronal Architecture of the Hippocampus in a 6-Hydroxydopamine-Lesioned Rat Model of Parkinson Disease
Bohye Kim et al.
INTERNATIONAL NEUROUROLOGY JOURNAL (2022)
Analysis of α-synuclein levels related to LRRK2 kinase activity: from substantia nigra to urine of patients with Parkinson's disease
Daleum Nam et al.
ANIMAL CELLS AND SYSTEMS (2021)
ERK signalling: a master regulator of cell behaviour, life and fate
Hugo Lavoie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
The Role of PI3K/Akt and ERK in Neurodegenerative Disorders
Sachchida Nand Rai et al.
NEUROTOXICITY RESEARCH (2019)
GSK-3 at the Intersection of Neuronal Plasticity and Neurodegeneration
Tomasz Jaworski et al.
NEURAL PLASTICITY (2019)
Impaired dopamine metabolism in Parkinson's disease pathogenesis
Anna Masato et al.
MOLECULAR NEURODEGENERATION (2019)
Dopamine: Functions, Signaling, and Association with Neurological Diseases
Marianne O. Klein et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2019)
The 6-hydroxydopamine model and parkinsonian pathophysiology: Novel findings in an older model
D. Hernandez-Baltazar et al.
NEUROLOGIA (2017)
Assembly of Excitatory Synapses in the Absence of Glutamatergic Neurotransmission
Richard Sando et al.
NEURON (2017)
GSK3 isoform-selective regulation of depression, memory and hippocampal cell proliferation
M. Pardo et al.
GENES BRAIN AND BEHAVIOR (2016)
The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress
Hugo Juarez Olguin et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease
Mojtaba Golpich et al.
PHARMACOLOGICAL RESEARCH (2015)
Dopamine Receptors and Neurodegeneration
Claudia Rangel-Barajas et al.
AGING AND DISEASE (2015)
New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease
Paolo Calabresi et al.
LANCET NEUROLOGY (2013)
Cyclic AMP response element-binding protein (CREB) phosphorylation: A mechanistic marker in the development of memory enhancing Alzheimer's disease therapeutics
R. Scott Bitner
BIOCHEMICAL PHARMACOLOGY (2012)
Brain region differences in regulation of Akt and GSK3 by chronic stimulant administration in mice
Marjelo A. Mines et al.
CELLULAR SIGNALLING (2012)
Activity-dependent calcium signaling and ERK-MAP kinases in neurons: A link to structural plasticity of the nucleus and gene transcription regulation
J. Simon Wiegert et al.
CELL CALCIUM (2011)
GSK-3 beta activity and hyperdopamine-dependent behaviors
Yan-Chun Li et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Dopamine and adaptive memory
Daphna Shohamy et al.
TRENDS IN COGNITIVE SCIENCES (2010)
Akt signal transduction dysfunction in Parkinson's disease
Suzanne Timmons et al.
NEUROSCIENCE LETTERS (2009)
Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease
J. K. Morris et al.
BRAIN RESEARCH (2008)
The Hippocampus and Dopaminergic Midbrain: Old Couple, New Insights
Dharshan Kumaran et al.
NEURON (2008)
Glycogen synthase kinase 3: A key regulator of cellular fate
J. E. Forde et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
JM Beaulieu et al.
CELL (2005)
Phosphorylation of ERK and CREB in cultured hippocampal neurons after haloperidol and risperidone administration
BH Yang et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2004)
Chronic activation of ERK and neurodegenerative diseases
L Colucci-D'Amato et al.
BIOESSAYS (2003)
Activity-dependent CREB phosphorylation: Convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway
GY Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
